Low-dose dexmedetomidine facilitates the carotid body response to low oxygen tension in vitro via α2-adrenergic receptor activation in rabbits

European Journal of Anaesthesiology

Volumn 29, Issue 12, 2012, Pages 570-576

  Nakatani, Hidehiko ^a   Kim, Chol ^a   Sakamoto, Atsuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

2 adrenergic receptor; Action potential; Carotid body; Dexmedetomidine; Low oxygen tension; Respiratory system; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; DEXMEDETOMIDINE; POTASSIUM ION; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBON DIOXIDE TENSION; CAROTID BODY; CAROTID SINUS NERVE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL RABBIT; LOW DRUG DOSE; LOW OXYGEN TENSION; NERVE POTENTIAL; NONHUMAN; OXYGEN TENSION; PH; TISSUE PERFUSION;

ACTION POTENTIALS; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANALGESICS, NON-NARCOTIC; ANESTHETICS; ANIMALS; CAROTID BODY; CAROTID SINUS; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN-ION CONCENTRATION; MALE; OXYGEN; RABBITS; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION; YOHIMBINE;

EID: 84872231461     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328356fba5     Document Type: Article

References (25)

1. Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol 2008; 21:457-461.
2. Coursin DB, Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care 2001; 7:221-226.
3. Kamibayashi T, Maze M. Clinical uses of a2-adrenergic agonists. Anesthesiology 2000; 93:1345-1349.
4. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93:382-394.
5. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000; 4:302- 308.
6. Nishida T, Nishimura M, Kagawa K, et al. The effects of dexmedetomidine on the ventilatory response to hypercapnia in rabbits. Intensive Care Med 2002; 28:969-975.
7. Fernandes FC, Ferreira HC, Cagido VR, et al. Effects of dexmedetomidine on respiratory mechanics and control of breathing in normal rats. Respir Physiol Neurobiol 2006; 154:342-350.
8. Nguyen D, Abdul-Rasool I, Ward D, et al. Ventilatory effects of dexmedetomidine, atipamezole, and isoflurane in dogs. Anesthesiology 1992; 76:573-579.
9. Prabhakar NR. O2 sensing at the mammalian carotid body: why multiple O2 sensors and multiple transmitters? Exp Physiol 2006; 91:17-23.
10. Prabhakar NR, Overholt JL. Cellular mechanisms of oxygen sensing at the carotid body: heme proteins and ion channels. Respir Physiol 2000; 122:209-221.
11. Kou YR, Ernsberger P, Cragg PA, et al. Role of alpha 2-adrenergic receptors in the carotid body response to isocapnic hypoxia. Respir Physiol 1991; 83:353-364.
12. Prabhakar NR, Kou YR. Inhibitory sympathetic action on the carotid body responses to sustained hypoxia. Respir Physiol 1994; 95:67-79.
13. Ernsberger P, Kou YR, Prabhakar NR. Carotid body I1-imidazoline receptors: binding, visualization and modulatory function. Respir Physiol 1998; 112:239-251.
14. Jonsson MM, Lindahl SG, Eriksson LI. Effect of propofol on carotid body chemosensitivity and cholinergic chemotransduction. Anesthesiology 2005; 102:110-116.
15. Akada S, Fagerlund MJ, Lindahl SG, et al. Pronounced depression by propofol on carotid body response to CO2 and Ko-induced carotid body activation. Respir Physiol Neurobiol 2008; 160:284-288.
16. Kim C, Shvarev Y, Takeda S, et al. Midazolam depresses carotid body chemoreceptor activity. Acta Anaesthesiol Scand 2006; 50:144-149.
17. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I: Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77:1125-1133.
18. Hsu YW, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics. Part I: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101:1066-1076.
19. Rives JE, Bernard DG. a2 Adrenergic receptors and the central control of breathing in the cane toad, Bufo marinus. Respir Physiol 2001; 125:213- 223.
20. Nurse CA, Zhang M. Acetylcholine contributes to hypoxic chemotransmission in co-cultures of rat type 1 cells and petrosal neurons. Respir Physiol 1999; 115:189-199.
21. Varas R, Alcayaga J, Iturriaga R. ACh and ATP mediate excitatory transmission in cat carotid identified chemoreceptor units in vitro. Brain Res 2003; 988:154-163.
22. Jonsson M, Kim C, Yamamoto Y, et al. Atracurium and vecuronium block nicotine-induced carotid body chemoreceptor responses. Acta Anaestheiol Scand 2002; 46:488-494.
23. Igarashi A, Amagasa S, Horikawa H, Shirahata M. Vecuronium directly inhibits hypoxic neurotransmission of the rat carotid body. Anesth Analg 2002; 94:117-122.
24. Kosugi T, Mizuta K, Fujita T, et al. High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without a2 adrenoceptor activation. Br J Pharmacol 2010; 160:1662-1676.
25. Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997; 85:1136-1142.